Bio-Rad Laboratories, Hercules, CA, USA
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
IVD Logix LLC, Dallas, TX, USA
Lophius Biosciences GmbH, Regensburg, Germany
Johnson & Johnson, USA
MOBILion Systems, Chadds Ford, PA, USA
Market Diagnostics International LLC, Dallas, TX, USA
ODx Innovations, Inverness, Scotland, UK
Precision for Medicine Group, Inc., Frederick, MD, USA
Prolocor Inc., Philadelphia, PA, USA
Roche Diagnostics, Global Business Development, Pleasanton, CA, USA
Roche Sequencing Solutions, Pleasanton, CA, USA
Sense Biodetection Ltd, Oxford, UK
Singulex Inc., Alameda, CA, USA
World Health Organisation, Geneva, Switzerland
Alere Inc (Abbott Laboratories), Waltham, MA, USA
Agilent Technologies Inc, Santa Clara, CA, USA
Becton Dickinson and Company, Franklin Lakes, NJ, USA
DeBiopharm Group, Lausanne, Switzerland
GenePOC Inc., Quebec, Canada
LuminUltra Technologies Ltd, Fredericton, Canada
The MedTech Strategist, USA
Millipore Sigma, St Louis, MO, USA
SeeGene Inc., Walnut Creek, CA, USA
STAT-Diagnostica and Innovation S.L, Barcelona, Spain
Thermo Fisher Scientific, Waltham, MA, USA
Wako Diagnostics, Moutainview, CA, USA
Molecular Medicine Triconference (San Francisco, March 2020)
Title: How Infectious Disease Molecular Multiplexing is Shaping Up (Part I): Market Environment and Competitive Landscape
Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2019)
Title: Trends and Countertrends in Point of Care Testing
DxMA Seminar at the Association of Molecular Pathologists (AMP) conference (November 2016)
Title: Counter Trends in Global Infectious Disease Testing: To Decentralise Molecular Testing or Not